By Jo Cavallo  / November 2019  / 2019 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

AACR-NCI-EORTC: Activity of Tipifarnib in Patients With HRAS-Mutant Head and Neck Squamous Cell Carcinoma

A small phase II study investigating the efficacy and safety of the investigational farnesyl transferase inhibitor tipifarnib in patients with recurrent and metastatic HRAS-mutant head and neck squamo...